1. Home
  2. POET vs HQL Comparison

POET vs HQL Comparison

Compare POET & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$6.11

Market Cap

550.2M

Sector

Technology

ML Signal

HOLD

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$16.60

Market Cap

510.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
HQL
Founded
1972
1992
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Investment Managers
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
550.2M
510.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POET
HQL
Price
$6.11
$16.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.0M
120.9K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
$762,695.00
N/A
Revenue This Year
$2,939.08
N/A
Revenue Next Year
$710.17
N/A
P/E Ratio
N/A
$17.08
Revenue Growth
535.87
N/A
52 Week Low
$3.09
$11.34
52 Week High
$9.41
$14.37

Technical Indicators

Market Signals
Indicator
POET
HQL
Relative Strength Index (RSI) 52.69 43.96
Support Level $5.81 $17.03
Resistance Level $6.59 $17.25
Average True Range (ATR) 0.56 0.31
MACD 0.06 -0.09
Stochastic Oscillator 52.46 14.29

Price Performance

Historical Comparison
POET
HQL

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Share on Social Networks: